HPK1-IN-7

Modify Date: 2024-02-01 20:37:20

HPK1-IN-7 Structure
HPK1-IN-7 structure
Common Name HPK1-IN-7
CAS Number 2320462-65-3 Molecular Weight 458.47
Density N/A Boiling Point N/A
Molecular Formula C24H22N6O4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of HPK1-IN-7


HPK1-IN-7 is a potent, orally active HPK1 (hematopoietic progenitor kinase 1, MAP4K1) inhibitor (IC50=2.6 nM) with excellent family and kinome selectivity. HPK1-IN-7 shows selectivity against IRAK4 (59 nM) and GLK (140 nM). HPK1-IN-7 shows robust efficacy against MC38 syngeneic tumor model in combination with anti-PD1[1].

 Names

Name HPK1-IN-7
Synonym More Synonyms

 HPK1-IN-7 Biological Activity

Description HPK1-IN-7 is a potent, orally active HPK1 (hematopoietic progenitor kinase 1, MAP4K1) inhibitor (IC50=2.6 nM) with excellent family and kinome selectivity. HPK1-IN-7 shows selectivity against IRAK4 (59 nM) and GLK (140 nM). HPK1-IN-7 shows robust efficacy against MC38 syngeneic tumor model in combination with anti-PD1[1].
Related Catalog
Target

HPK1:2.6 nM (IC50)

GLK/MAP4K3:140 nM (IC50)

IRAK4:59 nM (IC50)

Fms/CSFR:3.2 nM (IC50)

FLT3:25.4 nM (IC50)

AMPKA1:44.3 nM (IC50)

cKIT:45.7 nM (IC50)

MST1:55.1 nM (IC50)

ICK:65.1 nM (IC50)

MST2:78.5 nM (IC50)

In Vivo HPK1-IN-7 (100 mg/kg; p.o.; twice daily for 28 days) shows robust enhancement of anti-PD1 efficacy in a syngeneic tumor model of colorectal cancer[1]. HPK1-IN-7 (compound 24) (1 mg/kg; intravenous; mice) is characterized by moderate plasma clearance (43 mL/min/kg) and a large volume of distribution (4.4 L/kg). After oral administration (20 mg/kg), the Cmax was 5.3 μM and the AUC0-24h was 19 μM•h. The calculated oral bioavailability based on these pharmacokinetics studies is approximately 100%[1]. Animal Model: Mice (MC38 syngeneic tumor model)[1] Dosage: 100 mg/kg Administration: Oral; twice daily for 28 days Result: Enhanced the efficacy of anti-PD1 treatment, garnering a 100% cure rate vs a 20% cure rate with anti-PD1 alone.
References

[1]. Degnan AP, et al. Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1. ACS Med Chem Lett. 2021;12(3):443-450. Published 2021 Feb 19.

 Chemical & Physical Properties

Molecular Formula C24H22N6O4
Molecular Weight 458.47

 Synonyms

1(3H)-Isobenzofuranone, 5-[[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]-5-(1,3,4-oxadiazol-2-yl)-2-pyrimidinyl]amino]-3,3-dimethyl-
Top Suppliers:I want be here

Get all suppliers and price by the below link:

HPK1-IN-7 suppliers


Price: ¥3500/5 mg

Reference only. check more HPK1-IN-7 price